Table 6.
Risk factors for 30-day mortality in all infected patients
| Odds ratio | 95% CI | p value | |
|---|---|---|---|
| Age, per year increase | 1.02 | 1.012–1.031 | < 0.001 |
| APACHE II score at admission, per point increase | 1.02 | 1.006-1.036 | 0.005 |
| SOFA score on study day, per point increase | 1.115 | 1.067–1.165 | < 0.001 |
| Comorbid condition | |||
| Solid organ malignancy | 1.924 | 1.081–3.425 | 0.026 |
| Clinical condition | |||
| Infectiona | |||
| Infection + SIRS | 1.617 | 0.986–2.651 | 0.057 |
| Severe sepsis | 4.659 | 2.875–7.548 | < 0.001 |
| Septic shock | 3.326 | 2.152–5.141 | < 0.001 |
| Infections | |||
| Candida spp. | 3.526 | 1.437–8.653 | 0.006 |
| Therapies | |||
| RRT | 2.675 | 1.702–4.206 | < 0.001 |
| Nurse to patient ratio | |||
| 1:2a | |||
| 1:3 | 1.43 | 0.977–2.014 | 0.066 |
| 1:4 | 1.958 | 1.259–3.043 | 0.003 |
Model log-likelihood: -474.943; F: 15.15; p ≤ 0.001. Hosmer-Lemeshow X2 = 10.3; p = 0.245
CI confidence interval, APACHE II acute physiology and chronic health evaluation, SOFA sequential organ failure assessment, SIRS systemic inflammatory response syndrome, RRT renal replacement therapy
aReference group